The aim of our study is to detect polymorphisms and expression levels of the A20, CYLD and Cezanne genes and to determine their associations with leukocyte and lymphoblast accumulation and clinical features in B-ALL patients. The gene discussed is CYLD; the disease is acute lymphoblastic leukemia.